Publicaciones en las que colabora con Ana M. Peiró Peiró (7)

2013

  1. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart

    Psychopharmacology, Vol. 225, Núm. 4, pp. 883-893

2007

  1. Pharmacological interaction between 3,4-methylenedioxymethamphetamine (ecstasy) and paroxetine: Pharmacological effects and pharmacokinetics

    Journal of Pharmacology and Experimental Therapeutics, Vol. 323, Núm. 3, pp. 954-962

2005

  1. Contribution of cytochrome P450 2D6 to 3,4-methylenedioxymethamphetamine disposition in humans: Use of paroxetine as a metabolic inhibitor probe

    Clinical Pharmacokinetics, Vol. 44, Núm. 6, pp. 649-660

2004

  1. Repeated doses administration of MDMA in humans: Pharmacological effects and pharmacokinetics

    Psychopharmacology, Vol. 173, Núm. 3-4, pp. 364-375

  2. Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its main metabolites in human samples including the catechol-type metabolite (3,4-dihydroxymethamphetamine)

    Drug Metabolism and Disposition, Vol. 32, Núm. 9, pp. 1001-1007

2003

  1. Estudios controlados en humanos de éxtasis

    Adicciones: Revista de socidrogalcohol, Vol. 15, Núm. 2, pp. 121-134

2001

  1. Efectos farmacológicos y farmacocinética del éxtasis tras la administración de dos dosis repetidas en humanos

    Trastornos adictivos: Organo Oficial de la Sociedad española de Toxicomanías, Vol. 3, Núm. 4, pp. 289-289